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Abstract 
Objective(s): The radial artery (RA) is often used as a second arterial conduit in 
preference to the right internal thoracic artery in obese patients undergoing coronary 
artery bypass grafting (CABG) to minimise the risk of sternal wound complication. 
However, obesity has been found to promote RA vasoreactivity and early 
atherosclerotic degeneration, which may compromises graft patency when used in 
patients having CABG. Therefore, we investigated the effect of the RA as second 
conduit, when compared with the saphenous vein (SV) on the long term survival in 
obese and  non-obese patients undergoing first time CABG.  
Methods: Propensity score matching was used to adjust for imbalance and the effect 
of the RA in obese (body mass index, BMI≥30) and non-obese (BMI<30) subjects was 
tested by means of time segmented Cox regression.  
Results: The study population consisted of 12244 patients undergoing first time 
CABG. Of those, 8740 subjects were non-obese and 3504 obese. The RA was used 
as second arterial conduit in 1322 (15%) non-obese patients and 685(20%) obese 
patients. The use of the RA when compared to saphenous vein, reduced the risk of 
late death in subjects with BMI<30 (HR 0.75;95%CI0.62-0.89;P=0.001) but not in 
those with BMI≥30 (HR0.88;95%CI0.68-1.13;P=0.3), regardless of their diabetes 
status (non-diabetic HR 0.87[0.63-1.20] versus diabetics HR 0.83[0.54-
1.26];interaction P=0.8).  
Conclusion: The use of the RA in preference to SV as second conduit was associated 
with improved long term survival in non-obese patient undergoing CABG. This benefit 
was no longer present in obese patients regardless of their diabetes status. 
Keywords: coronary artery bypass graft; obesity; arterial graft  
Introduction 
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Worldwide obesity has more than doubled since 1980. In 2014, more than 1.9 billion 
adults, 18 years and older, were overweight, and 600 million obese. Obesity is a 
major risk factor for coronary artery disease, the leading cause of death in 2012 [1]. 
As a consequence the impact of obesity on outcomes after coronary artery bypass 
graft (CABG) surgery has become a focus of increasing attention [2]. High body 
mass index (BMI) has been consistently associated with poorer long-term survival 
[3]. Its detrimental effect has been attributed to the progression of earlier grafts 
atherosclerosis [4] which leads to a greater risk of clinical events [5]. 
Arterial grafts when compared with saphenous vein (SV) grafts, would be expected to 
provide a survival benefit in obese patients due to their reduced susceptibility to 
atherosclerosis [6].  The right internal thoracic artery as second arterial conduit, has 
been demonstrated to be associated with survival benefit in obese undergoing CABG 
[6], however, surgeons continue to be reluctant to use it in this high risk subgroup 
because of the potential for sternal wound complications [7,8]. This often results in the 
RA to be preferred as the second conduit of choice in obese patients [9].  However, 
obesity is associated with chronic systemic inflammation, endothelial dysfunction, 
renin-angiotensin and sympathetic nervous systems activation [10] which can 
enhance the RA vasoreactivity and early atherosclerosis [11-14]. In the present study 
we tested the hypothesis that the survival benefit from the RA over the SV might be 
reduced in obese when compared to non-obese patients undergoing first time CABG.  
Methods 
The study was conducted in accordance with the principles of the Declaration of 
Helsinki. The local audit committee approved the study, and the requirement for 
individual patient consent was waived. We retrospectively analysed prospectively 
collected data from The National Institute for Cardiovascular Outcomes Research 
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(NICOR) NACSA registry on 1 June 2015 for all isolated first time CABG procedures 
performed at the Bristol Heart Institute, Bristol United Kingdom from 1996 to April 
2015.  Reproducible cleaning algorithms were applied to the database, which are 
regularly updated as required. Briefly, duplicate records and non-adult cardiac surgery 
entries were removed; transcriptional discrepancies harmonized; and clinical conflicts 
and extreme values corrected or removed. The data are returned regularly to the local 
units for validation.  
Further details and definition of variables are available at 
http://www.ucl.ac.uk/nicor/audits/adultcardiac/datasets. Among 12247 isolated first 
time CABG cases performed during the study period, we selected subjects who met 
the following criteria: multivessel coronary disease including left main and/or left 
anterior descending (LAD) coronary disease; requiring at least 2 grafts; CABG 
performed by using the following strategies: left internal thoracic artery (LITA) grafting 
and RA as second arterial conduit with or without additional SV grafts (RA group) or 
LITA grafting with additional SV grafts only (SV group). In the present series, the RA 
was considered only in case of target stenosis ≥75% and it was used as a free conduit 
proximally connected to the ascending aorta or as a composite y graft to the LITA. The 
LITA was used as in-situ to graft the LAD territory. We classified anyone with a BMI of 
30 kg/m2 and higher as obese, in line with the National Heart Lung and Blood Institute 
classification of obesity.  
End-points 
Primary end point was all-cause early (within 30 days) and late (beyond 30 days) 
mortality. All-cause mortality is the most robust and unbiased index because no 
adjudication is required; thus, inaccurate or biased documentation or clinical 
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assessments are avoided [15]. Information about death was obtained from the 
institutional database and the General Register Office for all patients.  
Statistical analysis 
For baseline characteristics, variables are summarized as median with relative 
interquartile range (IQR) for continuous variables and proportion for categorical 
variables. Multiple imputation was used to address missing data 
(http://www.jstatsoft.org/v45/i07/). To control for measured potential confounders in 
the data set, a propensity score (PS) matching was used. PS was generated for each 
patient from a multivariable logistic regression model based on pre-treatment 
covariates as independent variables with treatment type (RA versus SV) as a binary 
dependent variable (http://CRAN.Rproject.org/package=nonrandom). Variables used 
in the propensity match included: age, gender, BMI, baseline creatinine≥200mmol/l, 
diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), left ventricular 
ejection fraction (LVEF) ≤49%, previous myocardial infarction (MI), previous 
percutaneous coronary intervention (PCI), previous cerebrovascular accident (CVA), 
hypertension, current smoking, peripheral vascular disease (PVD), preoperative atrial 
fibrillation (AF), non-elective surgery, preoperative use of intra-aortic balloon pump 
(IABP), vessels diseased including diagonal branch (DIA), circumflex artery (CX) and 
right coronary artery (RCA) and year of operation. Pairs of patients receiving RA and 
SV were derived using greedy 1:1 matching with a calliper of width of 0.2 standard 
deviation of the logit of the PS. Time segmented Cox regression (within 30 days and 
beyond 30 days from surgery) was used to investigate the influence of the RA on 
survival. Second-order interaction between the treatment indicator and BMI 
(RAvsSV*BMI) in the matched sample was forced in a time segmented Cox model for 
early (within 30 days) and late hazard phases (beyond 30 days). BMI linearity was 
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assessed using a likelihood ratio test, including age as either a linear term or with a 
restricted spline fit. The likelihood ratio test showed that the cubic term for BMI yielded 
a better fit than the linear model (X2=12; P=0.002). A Schoenfeld residuals test ruled 
out violation of the proportional hazard assumption (P=0.50). The effect of the RA 
across BMI values on late mortality was obtained using nonparametric bootstrap 
covariance analysis for regression coefficients (n = 500 repetitions) (rms R package 
version 4.2-0: http://CRAN.R-project.org/package=rms). As sensitivity analysis, the 
effect of the RA on late mortality was tested across BMI categories normal weight 
(BMI, 18.5-24.9 kg/m2), overweight (BMI, 25-29.9 kg/m2), obese (BMI, 30-34.9 kg/m2), 
and severely obese (BMI ≥ 35 kg/m2) .  All p-values <0.05 were considered to indicate 
statistical significance. All statistical analysis was performed using R Statistical 
Software (version 3.2.3; R Foundation for Statistical Computing, Vienna, Austria). 
Results 
Study population 
The study population consisted of 12244 patients (median age 68 years, IQR 61-74). 
Of those, 8740 subjects were non-obese (BMI<30, median BMI 26, IQR 24-28) and 
3504 obese (BMI≥30, median BMI 32, IQR 31-35). The RA was used in 1322(15%) 
non-obese patients and 685(20%) obese patients. Number of procedures using the 
radial artery (RA) or the saphenous vein only (SV) among non-obese (BMI<30) and 
obese patients (BMI≥30) during the study period are summarized in Figure 1. Mean 
number of grafts was 2.80±0.70 versus 2.87±0.67 in the RA and SV groups 
respectively (P<0.001). In the non-obese group, the RA was used to graft the right 
coronary artery (RCA) in 316(24%) cases and the circumflex artery in 1006(76%) 
cases. In the obese group, the RA was used to graft the right coronary artery (RCA) 
in 150(22%) cases and the circumflex artery in 535(78%) cases.  
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Pre-treatment variables distributions in RA group and in unmatched and PS-matched 
SV groups are summarized in Table 1. Before PS matching the two groups were not 
comparable for all but four of pre-treatment variables. PS matching selected 2007 SV 
patients with pre-treatment variables distributions similar to those in the RA group 
including both BMI categories as well as mean number of grafts (2.80±0.70 versus 
2.81±0.70 in the RA and SV groups respectively; P=0.65). 
Effect of the RA on early and late survival 
In the RA group there were 8(0.4%) early deaths (within 30 days) compared to 
160(1.6%) in the unmatched SV group (HRearly phase 0.25; 95%CI 0.12-0.51; P<0.001) 
and 18(0.9%) in the PS-matched SV group (HRearly phase 0.44; 95%CI 0.19-1.02; 
P=0.06). After a median follow-up time of 7.5 years (IQR 3.6-11.3), survival probability 
at 5, 10 and 15 years in the RA group were 93.8%±0.6%, 84.2%±0.9% and 
69.4%±1.9% compared to 87.7%±0.3%, 70.9%±0.5% and 51.4%±0.08% in the 
unmatched SV group (HRlate phase 0.54; 95%CI 0.48-0.60; P<0.0001, Figure 2, left) and 
90.9%± 0.7%, 79.5%±1.1% and 63.9%±1.6% in the PS-matched SV group (HRlate phase 
0.86; 95%CI 0.74-0.99;P=0.04, Figure 2, right).  
Impact of body mass index on mortality 
BMI did not modify the effect of the RA on early mortality (interaction P=0.43) but there 
was a significant interaction between BMI and the use of the RA over SV on late 
mortality (interaction P=0.02). In particular, the survival advantage conferred by the 
RA gradually declined with increasing patient’s BMI and it was no longer statistically 
significant above a BMI >29 (Figure 3). The use of the RA reduced the risk of late 
death in subjects with BMI<30 (HRlate phase 0.78; 95%CI 0.65-0.94; P=0.008; Figure 4, 
left) but not in those with BMI≥30 (HRlate phase 1.05; 95%CI 0.80-1.38; P=0.72; Figure 
4, right). Finally we found a significant interaction between diabetes and effect of the 
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RA in non-obese patients with a larger benefit among non-diabetics (HRlate phase 
0.69[0.56-0.85]) when compared to diabetics (HRlate phase 0.81[0.45-0.99], interaction 
P=0.01). However, we could not demonstrated a significant survival benefit in obese 
patients regardless of their diabetes status (non-diabetic HRlate phase 0.87[0.63-1.20] 
versus diabetics HRlate phase 0.83[0.54-1.26]; interaction P=0.8).  
Discussion 
The main finding of the present study is that the use of the RA in preference to SV as 
second conduit was associated with improved long term survival in non-obese patient 
undergoing CABG. The RA-related benefit was more pronounced in the absence of 
diabetes. However, this benefit was no longer present in obese patients regardless of 
their diabetes status. 
In recent years, the obesity epidemic is growing both in the general population [1] and 
in patients undergoing CABG [2,3]. Obesity has been associated with poorer long term 
outcomes, after CABG, explained by the accelerated atherosclerotic graft progression 
[4,5]. The use of additional arterial conduits to the standard left internal thoracic artery 
has been advocated to improve survival after CABG given the up to 50% failure of SV 
grafts graft at 10 years post-surgery [16]. The RA is often preferred over the second 
internal thoracic artery in obese patients to reduce the potential sternal wound 
complication [7,8]. However, obesity has been reported to promote RA vasoreactivity 
and early inflammation, myointimal hyperplasia and atherosclerotic degeneration in 
other clinical settings [10-14] and these observations raise concern on the efficacy of 
the RA as a second arterial graft in this population.     
Obese patients have high levels of serum hs-CRP, which is known to trigger 
myointimal hyperplasia and a higher tendency of atheroma and calcification of the RA 
[11], suggesting the possibility of pre-existing vascular disease in those patients. 
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Moreover adiponectin, an adipocyte-derived collagen-like protein is decreased in 
obesity and this has been suggested to promote the production of adhesion molecules 
in endothelial cells, proliferation of smooth muscle cells and endothelial dysfunction 
[10], increased neo-intimal hyperplasia and atherosclerosis changes in  the RA of 
obese adults [17].  
No previous study has investigated the influence of obesity on survival in patients 
undergoing CABG using the RA as second conduit in preference to SV grafts. In the 
present analysis we demonstrated that the survival advantage in non-obese patients 
by using the RA is no longer present in obese patients regardless their diabetic status.   
In a previous study we found that the use of bilateral internal thoracic arteries improves 
survival in obese patients undergoing CABG when compared to the conventional 
strategy with a single internal thoracic artery [6].  It can be speculated that compared 
to the RA, internal thoracic arteries might be more resistant to atherosclerosis in obese 
subjects thus achieving a better patency rate because of their capacity to release nitric 
oxide [18,19].  
The present study has some limitations. The study was observational on prospectively 
collected data which cannot exclude the role of selection bias. Propensity technique 
can adjust only for measurable and included variables and we cannot exclude a 
selection bias based on non-measurable “eye-ball” variables (with the RA reserved to 
healthier and better patients). We did not measure the changes in the BMI during the 
follow-up period; hence, no causality of the interrelationship between these 
parameters could be determined. In addition, obesity was defined only by the BMI in 
the present study, rather than by an actual measure of adiposity, such as the 
waist circumference. However, the BMI is a widely available, simple, and practical 
measurement of obesity, and numerous studies have used BMI as a surrogate 
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measure of adiposity [20]. The long period of enrolment could theoretically have 
affected the preference of radial artery as a possible conduit. As shown in Figure 1 the 
rate of RA usage did not vary remarkably during the years and we have included the 
era of surgery in the PS model to account for this confounding factor. However, we 
cannot exclude residual patient selection bias. Finally, no follow-up data were 
available to compare the groups with respect to the cause of death (cardiac vs 
noncardiac), recurrence of angina, need for repeated revascularization, and graft 
patency. Therefore we can only speculate that the mechanism beyond differences in 
survival rate observed among the groups is related to the differences in patency rates 
of the RA over the SV. 
In conclusion, the survival benefit conferred by the use of the RA in preference to SV, 
among non-obese patients undergoing CABG, was no longer present in obese 
patients regardless of their diabetic status. Further studies are warranted to determine 
the pathophysiology underlying this observation and to identify which subgroup of 
obese patients is more likely to benefit from the use of the RA.     
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Table 1.  Pre-treatment variable distribution in the radial artery (RA) group and in the 
unmatched (um) and  propensity score matched (m) saphenous vein (SV) group  
                              RA group 
N=2007 
Um-SV group 
N=10237 
P m-SV group 
N=2007 
P  
  N % N % 
 
N % 
 
Age  <60 yrs 865 43 1651 16 <0.001 879 44 0.62 
        60.0-69 800 40 3908 38 
 
798 40 
 
        70-79 308 15 4085 40 
 
303 15 
 
        ≥80 34 2 593 6 
 
27 1 
 
Female                        267 13 1897 19 <0.001 290 14 0.31 
BMI <18.5 6 0 100 1 <0.001 16 1 0.67 
        18.5-24.9 399 20 2594 25 
 
410 20 
 
        25.0-29.9 917 46 4724 46 
 
880 44 
 
        30.0-34.9 524 26 2201 22 
 
516 26 
 
        ≥35.0 161 8.0 618 6 
 
185 9 
 
MI                             900 45 5172 51 <0.001 926 46 0.42 
PCI                           109 5 568 6 0.87 122 6 0.41 
DM 358 18 1974 19 0.14 394 20 0.15 
Hypertension                  1368 68 7499 73 <0.001 1365 68 0.94 
Smoking                       315 16 1231 12 <0.001 345 17 0.21 
Creatinine≥200mmol             12 1 321 3 <0.001 18 1 0.36 
COPD                          181 9 1217 12 <0.001 184 9 0.91 
CVA                           114 6 912 9 <0.001 121 6 0.68 
PVD                          148 7 1164 11 <0.001 161 8 0.47 
AF                             53 2 396 4 0.01 54 3 1 
LVEF <.50                           409 20 2920 29 <0.001 433 22 0.37 
Preoperative IABP  12 1 197 2 <0.001 9 0 0.66 
Non elective                  819 41 4992 49 <0.001 837 42 0.58 
RCA                           1300 65 7290 71 <0.001 1234 62 0.06 
CX                            1625 81 8318 81 0.78 1620 81 0.87 
DIA                            484 24 2256 22 0.04 498 25 0.63 
LMD                           495 25 2729 27 0.07 489 24 0.85 
YOP 1996-2004 905 45 4285 42 <0.001 913 46 0.06 
         2005-2015 1102 55 5952 58 
 
1094 55 0.06 
BMI: body mass index; MI: myocardial infarction; PCI: percutaneous coronary 
intervention; DM: diabetes mellitus, COPD: chronic obstructive pulmonary disease; 
CVA: cerebrovascular accident; PVD: peripheral vascular disease; AF: atrial 
fibrillation; LVEF: left ventricular ejection fraction; IABP: intra-aortic balloon pump; 
RCA: right coronary artery; CX: circumflex; DIA: diagonal; LMD: left main disease; 
YOP: year of operation   
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Figure Legend 
Figure 1. Number of procedures using the radial artery (RA) or the saphenous vein 
only (SV) among non-obese (BMI<30) and obese patients (BMI≥30) during the study 
period.  
Figure 2. Survival curves for patients receiving the radial artery (RA) and saphenous 
vein (SV) in the unmatched and propensity score matched samples.  
Figure 3. Non parametric bootstrap 95% confidence limits set for the radial artery (RA) 
versus saphenous vein (SV) grafting hazard ratios for a variety of body mass index 
(BMI) on late (beyond 30 days) mortality 
Figure 4. Survival curves for patients receiving the radial artery (RA) and saphenous 
vein (SV) in propensity score matched non-obese and obese patients  
